| Authors: |
Pulsipher MA; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California., Lehmann LE; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Bertuch AA; Baylor College of Medicine, Center for Cell and Gene Therapy and Texas Children's Hospital, Houston, Texas., Sasa G; Baylor College of Medicine, Center for Cell and Gene Therapy and Texas Children's Hospital, Houston, Texas., Olson T; Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Nakano T; Children's Hospital Colorado, Aurora, Colorado., Gilio A; Pediatric Hematology & Oncology, Hackensack, NJ., Burroughs LM; Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Seattle, Washington., Lipton JM; Division of Hematology/Oncology and Cellular Therapy, Cohen Children's Medical Center of New York, New York., Huang JN; UCSF Benioff Children's Hospital and University of California, San Francisco, California., Dickerson K; UT Southwestern Medical Center, Dallas, Texas., Bertaina A; Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, California., Zhuang C; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California., Malsch M; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Fleming M; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Weller E; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Shimamura A; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts., Williams DA; Boston Children's Hospital and Harvard Medical School, Boston, Massachusetts. |
